AMP Associated Meetings

AMP Associated Meetings are those at which selected / invited AMP members present on topics related to molecular pathology. Contact for more information or to request an AMP speaker.




Home / Meetings

AMP at Associated Meetings


Cambridge Healthtech Institute's 14th Annual Molecular Diagnostics

Engaging the Practice of Bespoke Medicine

February 20-22, 2017

Moscone North Convention Center

San Francisco, CA

Conference Website


AMP Co-organized Keynote Session: Reimbursement Stories

  • Overview of AMP's Published Framework for Evidence Needed for Clinical Utility, presented by Vicky Pratt, PhD
  • Garnering Payer Support for Genomic Profiling by Demonstrating Clinical Utility, presented by Pranil Chandra, DO
  • NSCLC and Other Solid Tumors: Genetic Testing and Reimbursement, presented by Raj Emmadi, MD


AMP Co-organized Short Courses at Tri-Conference:

Sunday, February 19, 2017

Moscone North Convention Center

San Francisco, CA

Separate registration for short courses is required

2:00pm: NGS Assay Selection, Validation and Compliance

  • Eric Duncavage, M.D., Assistant Professor, Pathology & Immunology, Washington University School of Medicine (AMP 2016 Training & Education Committee, Member)
  • Christina Lockwood, Ph.D., DABCC, FACB, Assistant Professor, Department of Laboratory Medicine; Associate Director, Genetics and Solid Tumor Diagnostics Laboratory, University of Washington (AMP Member)
  • Shashikant Kulkarni, Ph.D., Professor, Molecular and Human Genetics, Baylor College of Medicine; Co-Vice Chair, Research, Molecular and Human Genetics, Baylor College of Medicine; CSO, Baylor Miraca Genetics Laboratories; Vice President, Operations, Baylor Miraca Genetics Laboratories (AMP Member)

5:30pm: Clinical Informatics: Returning Results from Big Data

  • Mark J. Routbort, M.D., Ph.D., Associate Professor, MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical Practice Committee)
  • Somak Roy, M.D., Assistant Professor, Director, Genetic Services and Molecular Informatics; Assistant Director, Molecular and Genomic Pathology Laboratory, University of Pittsburgh Medical Center (AMP Informatics Subdivision Representative to the AMP 2017 Program Committee)
  • Annette Meredith, Ph.D., Color Genomics, Inc. (AMP Informatics Subdivision Representative to the AMP Global 2017 Organizing Committee)

Association of Community Cancer Centers - Virtual Molecular Tumor Boards (Through 2017)

As molecular testing becomes more widely adopted in the community oncology setting, cancer programs can benefit from access to innovative formats to help ensure that communication and quality patient care standards are maintained. Several innovative ACCC member programs have begun using virtual tumor board models as part of the integration of molecular testing into practice.
The virtual format allows participation by a variety of providers across a wide geographic area. Members of multidisciplinary teams across sites are invited to join in the virtual discussion of cases and determine treatment  - regardless of the physical location of the patient and care team.
Building on interviews with select ACCC member programs, ACCC and our partner organization, the Association for Molecular Pathology (AMP), are developing a webinar series focused on virtual molecular tumor boards for lung and breast cancer. The 12-webinar series features case studies and robust discussions on molecular testing in the community setting.

ACCC Upcoming Webinar:
Using Virtual Molecular Tumor Boards to Access the Experts LIVE from ACCC 33rd National Oncology Conference

Thursday, Oct 20, 2016
11:40 AM - 12:25 PM CDT
Register Now for the Webinar

Joseph Kim, MD, MPH, MBA, Xaphesis
Annie Chapman, MPH, Seattle Cancer Care Alliance
Eric Duncavage, MD, Washington University in St. Louis
Mark S. Soberman, MD, MBA, FACS, Frederick Regional Health System

In this first webinar of the virtual molecular tumor board series, hear from a multidisciplinary panel on how cancer programs can form valuable relationships with research centers for access to experts to translate the latest developments in molecular testing to appropriate individual patient treatment recommendations. Compare various tumor board models, partnership benefits, and effective practices.

Save the date:

October 26, 2016
7:00 AM - 8:00 AM PST
Virtual Molecular Tumor Board
Presented by Seattle Cancer Care Alliance and SCCA network site, Summit Cancer Centers (Spokane)
Arvind Chaudhry, MD, PhD
V.K. Gadi, MD, PhD